Search research articles
Contact Us
Filters
Showing results (51-60 of 103) with videos related to
Page
of 11
Sort By:
Der Internist
|
February 5, 2016
[Current treatment strategies for follicular lymphoma]
W Hiddemann, E Hoster, C Schmidt, et al.
Leukemia
|
February 3, 2007
Sequence-dependent synergy of the proteasome inhibitor bortezomib and cytarabine in mantle cell lymphoma
O Weigert, A Pastore, M Rieken, et al.
Deutsche Medizinische Wochenschrift (1946)
|
June 24, 2004
[Prophylaxis and differential therapy of tumorlysis syndrome]
M Krych, M Dreyling, M Kneba, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2013
Waldenstrom's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
C Buske, V Leblond, M Dimopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2014
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Dreyling, M Ghielmini, R Marcus, et al.
Journal of Internal Medicine
|
March 16, 2017
Targeting of B-cell receptor signalling in B-cell malignancies
M Jerkeman, M Hallek, M Dreyling, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2016
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Dreyling, M Ghielmini, S Rule, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Dreyling, M Ghielmini, S Rule, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 22, 2012
Chronic myeloid leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Baccarani, S Pileri, J-L Steegmann, et al.
Leukemia
|
May 4, 2012
Proteasome inhibition leads to dephosphorylation and downregulation of protein expression of members of the Akt/mTOR pathway in MCL
G Hutter, Y Zimmermann, M Rieken, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 103) with videos related to
Sort By:
Page
of 11
Der Internist
|
February 5, 2016
[Current treatment strategies for follicular lymphoma]
W Hiddemann, E Hoster, C Schmidt, et al.
Leukemia
|
February 3, 2007
Sequence-dependent synergy of the proteasome inhibitor bortezomib and cytarabine in mantle cell lymphoma
O Weigert, A Pastore, M Rieken, et al.
Deutsche Medizinische Wochenschrift (1946)
|
June 24, 2004
[Prophylaxis and differential therapy of tumorlysis syndrome]
M Krych, M Dreyling, M Kneba, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2013
Waldenstrom's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
C Buske, V Leblond, M Dimopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2014
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Dreyling, M Ghielmini, R Marcus, et al.
Journal of Internal Medicine
|
March 16, 2017
Targeting of B-cell receptor signalling in B-cell malignancies
M Jerkeman, M Hallek, M Dreyling, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2016
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Dreyling, M Ghielmini, S Rule, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Dreyling, M Ghielmini, S Rule, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 22, 2012
Chronic myeloid leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Baccarani, S Pileri, J-L Steegmann, et al.
Leukemia
|
May 4, 2012
Proteasome inhibition leads to dephosphorylation and downregulation of protein expression of members of the Akt/mTOR pathway in MCL
G Hutter, Y Zimmermann, M Rieken, et al.
Page
of 11